Detalhe da pesquisa
1.
Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years.
Surg Endosc
; 32(1): 260-267, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664427
2.
Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
Surg Endosc
; 28(4): 1056-62, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24196558
3.
Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner.
Ann Surg
; 255(6): 1080-5, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22534421
4.
Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1ß levels.
BMJ Open Diabetes Res Care
; 9(1)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941551
5.
Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients.
PeerJ
; 5: e3443, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28649469
6.
Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity.
Surg Obes Relat Dis
; 6(2): 126-31, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20359665